NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Equipment and Supplies -- standards Remove constraint Subjects: Equipment and Supplies -- standards

Search Results

1. FDA should further integrate its review of cybersecurity into the premarket review process for medical devices

2. Medical product communications that are consistent with the FDA-required labeling: questions and answers

3. Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff

6. Design considerations and pre-market submission recommendations for interoperable medical devices: guidance for industry and Food and Drug Administration staff

7. Manufacturers sharing patient-specific information from medical devices with patients upon request: guidance for industry and Food and Drug Administration staff

8. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

9. Software as a medical device (SAMD): clinical evaluation : guidance for industry and Food and Drug Administration staff

10. Unique device identification: policy regarding compliance dates for class I and unclassified devices and certain devices requiring direct marking : immediately in effect guidance for industry and Food and Drug Administration staff

11. Recognition and withdrawal of voluntary consensus standards: guidance for industry and Food and Drug Administration staff

12. Use of International Standard ISO 10993-1: "Biological evaluation of medical devices - part 1 : evaluation and testing within a risk management process" : guidance for industry and Food and Drug Administration staff

13. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices): guidance for industry and Food and Drug Administration staff

14. Recommended content and format of non-clinical bench performance testing information in premarket submissions: guidance for industry and Food and Drug Administration staff

15. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

16. Unique device identification: convenience kits : guidance for industry and Food and Drug Administration staff

17. Changes to existing medical software policies resulting from section 3060 of the 21st Century Cures Act: guidance for industry and Food and Drug Administration staff

18. Process to request a review of FDA's decision not to issue certain export certificates for devices: guidance for industry and Food and Drug Administration staff